Pfizer-BioNTech COVID-19 vaccine eligibility expanded for latest round

The Central Epidemic Command Center (CECC) on Tuesday expanded eligibility for the latest round of COVID-19 vaccinations, allowing more people to get their first dose of the Pfizer-BioNTech COVID-19 vaccine and their second dose of the AstraZeneca vaccine.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)